首页> 美国卫生研究院文献>BMJ Open >Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial
【2h】

Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial

机译:在护理过渡时提高药品管理的安全性和连续性(ISComat):群体随机控制试验过程评估的协议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A key priority for the UK National Health Service and patients is to ensure that medicines are used safely and effectively. However, medication changes are not always optimally communicated and implemented when patients transfer from hospital into community settings. Heart failure is a common reason for admission to hospital. Patients with heart failure have a high burden of morbidity, mortality and complex pharmacotherapeutic regimens. The Improving the Safety and Continuity Of Medicines management at Transitions of care programme comprises a cluster randomised controlled trial which will test the effectiveness of a complex behavioural intervention aimed at improving medications management at the interface between hospitals discharge and community care. We will conduct a rigorous process evaluation to inform interpretation of the trial findings, inform implementation of the intervention on a wider scale and aid dissemination of the intervention.
机译:英国国家卫生服务和患者的关键优先事项是确保药品安全有效地使用。然而,当患者从医院转移到社区环境时,药物改变并不总是最佳地传达和实施。心力衰竭是入学医院的常见原因。心力衰竭患者具有高度的发病率,死亡率和复杂的药物治疗方案。在护理计划过渡时提高药品管理的安全性和连续性包括集群随机对照试验,该试验将测试复杂的行为干预的有效性,旨在改善医院解放和社区护理的界面处的药物管理。我们将开展严谨的过程评估,以便于解释试验结果,告知实施更广泛规模的干预并援助传播干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号